This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a prospective, pair-matched randomised trial, which was carried out in six nursing homes that represented the unit of randomisation. The method used for randomisation was not described. The patients were followed for 18 months after enrolment. Complete directives were reviewed and signed by the attending physicians. After one year, the health care facilitators contacted competent residents and proxies of incompetent residents to update the directives. Satisfaction questionnaires were completed at baseline, 6, 12 and 18 months after the beginning of the study. Seventy per cent of the intervention residents (444 out of 636) and 57% of the control residents (374 out of 656) completed the advance directives.
Analysis of effectiveness
It appears that the analysis has been limited to patients who completed the final assessment (treatment completers only). The primary outcomes used were: the choice of the advance directives (LMD, Do Not Resuscitate, or other such as living wills, directives, power of attorney and no hospital), satisfaction with health care, deaths, and hospitalisations.
The questionnaire used to estimate satisfaction was not described and relied on a prior study. The satisfaction score ranged from 0 (lowest) to 7 (highest). Consenting and no-consenting patients were comparable. Differences in the consent rate between the intervention and control homes were not statistically significant. However, there was a higher percentage of male residents in the intervention than in the control nursing homes (odds ratio 0.51, 95% confidence interval, CI: 0.35 -0.76). A weighted analysis of covariance was performed to determine whether there was a statistically significant difference in satisfaction between the groups.
Effectiveness results
In terms of the choice of the advance directive, 395 of the intervention group residents chose LMD, 27 chose Do Not Resuscitate, and 22 chose other directives. In the control group, 266 residents chose Do Not Resuscitate and 108 chose other directives.
More specifically, for irreversible conditions, 70% of competent residents chose palliative care, 47% basic feeding and 91% no CPR. For reversible conditions, 41% chose intensive care, 35% intravenous feeding and 67% no CPR. For irreversible conditions, 66% of proxies for incompetent residents chose palliative care, 56% supplemental feeding and 97% no CPR. For reversible conditions, 51% chose limited care, 48% supplemental feeding and 84% no CPR.
The mean satisfaction score for competent residents changed from 4.77 (standard deviation, SD=1.10) at baseline to 5.07 (SD=1.17) at the end of follow-up in the intervention group, and from 5.09 (SD=0.98) to 5.10 (SD=1.11) in the control group.
The post-intervention adjusted difference of -0.16 (95% CI: -0.41 -0.10) was not statistically significant, (p=0.24).
The mean satisfaction score (SD) for incompetent residents changed from 5.49 (1.04) at baseline to 5.71 (1.03) at the end of follow-up in the intervention group and from 5.44 (1.11) to 5.61 (1.15) in the control group.
The post-intervention adjusted difference of 0.07 (95%CI: -0.08 to 0.23) was not statistically significant, (p=0.37).
The proportion of deaths was 24% in the intervention group and 28% in the control group, (p=0.20).
The number of hospitalisations per patient was 0.27 in the intervention group versus 0.48 in the control group, (p=0.001). The number of hospitalised days per patient was 2.61 in the intervention group versus 5.86 in the control group, (p=0.01).
Clinical conclusions
The effectiveness analysis showed that the LMD programme was the most preferred alternative in the group of residents who received it. It reduced the length and number of hospitalisations in comparison with patients who did not receive this option, without increasing the death rate. There was no difference in the satisfaction of competent residents and the proxies of incompetent residents.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used in the economic evaluation. Therefore, the study was classified as a cost-consequences analysis.
Direct costs
Discounting was not relevant since the costs per patient were incurred during 18 months. The unit costs and the quantities of resources used were not presented separately. The health services included in the economic analysis were LMD programme, hospitalisations (tests, procedures, emergency department visits and inpatient days) and nursing home drugs. The cost/resource boundary adopted in the study appears to have been that of the third-party payer.
Resource use was estimated using the sample of patients who were included in the effectiveness study for the 18-month period, and the data were collected prospectively. A retrospective review of resource consumption in the 12 months prior to the implementation of the LMD programme was also carried out. This was based on patients different from those included in the prospective analysis of effectiveness. The costs were derived from the Ontario Case Costing Project, the Ontario provincial fee schedule, the Ontario Ministry of Health price list and the Ontario Drug Benefit formulary. A 10% pharmacy mark-up and a standard dispensing fee were added to each prescription. The price year was not explicitly stated, but most of the costs were estimated in 1997.
Statistical analysis of costs
The costs were presented as mean and median values. The unpaired t-test was used to test the statistical significance of differences between the costs estimated in the two groups.
